Retina Department, Okmeydanı Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Viransehir State Hospital, Eye Clinic, Urfa, Turkey.
Ocul Immunol Inflamm. 2019;27(8):1235-1241. doi: 10.1080/09273948.2019.1620786. Epub 2019 Aug 14.
: To evaluate the efficacy and safety of posterior 40 mg subtenon triamcinolone acetonide (PST) injection in treating Irvine-Gass syndrome.: The retrospective study included 21 patients (mean age: 76 ± 8.2) with a treatment-naïve eye subjected to topical anesthesia and injection of 40 mg/ml triamcinolone via a blunt tip SubTenon cannula through a single inferonasal peritomy. Best corrected visual acuity (BCVA; logMAR), intraocular pressure (IOP), biomicroscopic and funduscopic findings, and optical coherence tomography (OCT) measurements were recorded.: Baseline central macular thickness decreased from 431 ± 136 µm to 300 ± 67 µm (1st month; = .002), to 292 ± 56 µm (3rd month; = .002), and to 299 ± 66 µm (6th month; = .005). Mean BCVA increased from 0.71 ± 0.23 to 0.27 ± 0.11, 0.19 ± 0.06, and 0.24 ± 0.17, respectively (all visits; < 0.001). Mean IOP values did not change significantly ( = .12).: PST injection is an effective and safe treatment for Irvine-Gass syndrome.
评估后部 40 毫克曲安奈德经巩膜睫状体平坦部注射（PST）治疗 Irvine-Gass 综合征的疗效和安全性。
这项回顾性研究纳入了 21 名（平均年龄：76 ± 8.2）未经治疗的患者，他们的单眼接受局部麻醉，并通过钝头 SubTenon 套管注射 40mg/ml 的曲安奈德。记录最佳矫正视力（BCVA；logMAR）、眼压（IOP）、眼前节和眼底检查以及光学相干断层扫描（OCT）测量结果。
基线中央黄斑厚度从 431 ± 136μm 降低至 300 ± 67μm（第 1 个月； =.002）、292 ± 56μm（第 3 个月； =.002）和 299 ± 66μm（第 6 个月； =.005）。平均 BCVA 从 0.71 ± 0.23 分别增加至 0.27 ± 0.11、0.19 ± 0.06 和 0.24 ± 0.17（所有就诊时； < 0.001）。平均 IOP 值无显著变化（ =.12）。
PST 注射是 Irvine-Gass 综合征的一种有效且安全的治疗方法。
